Drugmakers are counting the cost of the deepening euro zone crisis, with further austerity-driven price cuts expected in important European markets, including Italy and France, said experts.
Growing alarm at multiple government-imposed cut

As sales of big-brand medicines in the United States and Europe falter, Western drug companies have new targets in their sights - the emerging wealthy middle classes of China, India and Russia.
And such a drive into new areas of double-dig